Mark E. Legaz
Impact in
- Hematology top 1%
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Genetics top 5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Venomous Animal Envenomation and Studies
Papers in
-
- Blood Coagulation and Thrombosis Mechanisms 3
- Hemophilia Treatment and Research 2
-
- RNA and protein synthesis mechanisms 1
- Protein purification and stability 1
- Co-authors
- Earl W. Davie (9 shared papers)Kazuo Fujikawa (6 shared papers)Gottfried Schmer (1 shared paper)Richard B. Counts (1 shared paper)Arthur R. Thompson (2 shared papers)Hisao Kato (2 shared papers)Robert G. Meyer (1 shared paper)Michael H. Coan (1 shared paper)
- Journals
- Biochemistry (5 papers)Annals of the New York Academy of Sciences (2 papers)Methods in enzymology on CD-ROM/Methods in enzymology (1 paper)Journal of Biological Chemistry (1 paper)Archives of Biochemistry and Biophysics (1 paper)
- Partner nations
- United States
In The Last Decade
Mark E. Legaz
12 papers receiving 960 citations
Peers
Comparison fields: 5 of 81
- Hematology 818
- Genetics 312
- Pulmonary and Respiratory Medicine 288
- Cancer Research 114
- Biotechnology 67
Countries citing papers authored by Mark E. Legaz
This map shows the geographic impact of Mark E. Legaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Legaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Legaz more than expected).
Fields of papers citing papers by Mark E. Legaz
This network shows the impact of papers produced by Mark E. Legaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Legaz. The network helps show where Mark E. Legaz may publish in the future.
Co-authors
The 16 scholars most cited alongside Mark E. Legaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1973 | 207 | |
| 2 | 1972 | 200 | |
| 3 | 1973 | 195 | |
| 4 | 1974 | 179 | |
| 5 | 1972 | 167 | |
| 6 | 1974 | 138 | |
| 7 | 1977 | 54 | |
| 8 | 1974 | 41 | |
| 9 | 1975 | 37 | |
| 10 | 1976 | 23 | |
| 11 | 1976 | 9 | |
| 12 | 1975 | 8 |
About Mark E. Legaz
Mark E. Legaz is a scholar working on Hematology, Molecular Biology, Genetics, Radiology, Nuclear Medicine and Imaging and Physiology, having authored 12 papers that have together received 1.3k indexed citations. Recurring topics across this work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Hemophilia Treatment and Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), RNA and protein synthesis mechanisms (1 paper), Blood properties and coagulation (1 paper), Protein purification and stability (1 paper) and Genetically Modified Organisms Research (1 paper). The work is most often cited by research in Hematology (818 citations), Genetics (312 citations), Pulmonary and Respiratory Medicine (288 citations), Cancer Research (114 citations) and Biotechnology (67 citations). Mark E. Legaz has collaborated with scholars based in United States. Frequent co-authors include Earl W. Davie, Kazuo Fujikawa, Gottfried Schmer, Richard B. Counts, Arthur R. Thompson, Hisao Kato, Robert G. Meyer, Michael H. Coan, Arthur B. Robinson and James H. McKerrow. Their work appears in journals such as Biochemistry, Annals of the New York Academy of Sciences, Methods in enzymology on CD-ROM/Methods in enzymology, Journal of Biological Chemistry and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.